  |
 |
|
|
 |
 |
 |
| |
|
|
|
DIAGNOSTICS of TîRCH-infections:
Toxoplasmosis, Rubella, Cytomegalovirus and Herpes Simplex Virus
Diaproph-Med manufactures the test
kit based on immunoassay for serological diagnostics of
TîRCH-infections, which includes the following test systems:
DIA-Toxo-IgG, DIA-Toxo-IgM, DIA-Rubella-IgG, DIA-Rubella-IgM,
DIA-CMV-IgG, DIA-CMV-IgM, DIA-HSV ½-IgG, DIA-HSV ½-IgÌ,
DIA-HSV 2-IgG, DIA-HSV 2-IgÌ
Test kits for diagnostics of toxoplasmosis
DIA-Toxo-IgG – Enzyme immunoassay for the quantitative detection of IgG class antibodies against Toxoplasma gondii.
DIA-Toxo-IgÌ – Enzyme immunoassay for the detection of IgM class antibodies against Toxoplasma gondii.
DIA-Toxo-IgG

Principle of the method: two stage procedure based on indirect solid ELISA
Clinical materials: human serum or plasma
Quantitative detection of the concentration of specific to Òoxoplasma gondii IgG antibodies in International Units (IU)
Included calibrators in the test kit are tittered against 3 International standards Anti-Toxoplasma serum, Human
Immunosorbent – purified specific antigens of Toxoplasma gondii.
Conjugate – high specific monoclonal antibodies to human IgG antibodies conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 2 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with purified antigens of Toxoplasma gondii
|
|
adding of sera
incubation for 60 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25°Ñ
reaction termination
result reading
|
DIA-Toxo-IgÌ

Principle of the method: two stage ELISA procedure based on «IgM-capture» principle
Clinical materials: human serum or plasma
Detection of specific to Toxoplasma gondii IgM antibodies
Immunosorbent – monoclonal antibodies to human IgM
Conjugate – purified membrane antigen of Toxoplasma gondii conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 2 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with monoclonal antibodies to human IgM
|
|
adding of sera
incubation for 30 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25°Ñ
reaction termination
result reading
|
Results of testing on serum panels containing and not containing
antibodies to Toxoplasma gondii in mixed titers - Anti-Toxoplasma Mixed
Titer Performance Panel PTT201, manufactured by BBI (USA) and positive
controls Accurun 135 Toxo IgG Positive Control (BBI, USA) and Accurun
136 Toxo IgÌ Positive Control (BBI, USA) in DIA-Toxo-IgG and
DIA-Toxo-IgÌ test kits are correspond to the data sheets.
Registration rate of IgG to T.gondii in different age groups
Diagnostics of toxoplasmosis from pregnant women: strategy of monitoring
(WHO recommendation) – initial testing.
Table 2
| Variant of investigation |
Result of IgG detection ( IU / ml ) |
Result of IgM detection |
Interpretation |
Recommendations |
| Variant À |
Negative <6 |
Negative |
Absence of i mmunity ( group of risk ) |
During pregnancy blood should be tested in each 4 weeks |
| Variant  1 |
Positive 6 < IU < 200 |
Negative |
P rotective immunity ( after undergone infection ) |
Repeated investigation of serrum in 2-3 weeks for confirmatory of protective immunity |
| Variant  2 |
Positive >200 |
Negative |
S uspicion of seroconversion |
Repeated investigation of serrum in 2-3 weeks for IgM , Ig À antibodie presence |
| Variant  3 |
Positive >6 |
Positive |
S uspicion of seroconversion |
Repeated investigation of serrum in 2-3 weeks |
| Variant Ñ |
Negative <6 |
Positive |
S uspicion of seroconversion |
Repeated investigation of serrum in 2-3 weeks |
Diagnostics of toxoplasmosis from pregnant women: strategy of monitoring
(WHO recommendation) – repeated testing.
Table 2
| Variant of investigation |
Result of IgG detection ( IU / ml ) |
Result of IgM detection |
Interpretation |
Recommendations |
| Variant Âà |
Positive ( increasing of the concentration in twice and more ) |
Positive |
Seroconversion |
Confirmation in others test kits and also IgA detection |
| Variant  b |
Positive ( without changing of the concentration ) |
Positive |
P rotective immunity ( after undergone infection more than 2 months ago ) |
Investigate in 2- 3 weeks for the purpose of confirmation of protective immunity |
| Variant Ñà |
Positive >6 |
Positive |
Seroconversion |
Confirmation in others test kits and also IgA detection |
| Variant Ñ b |
Negative <6 |
Positive |
Absence of i mmunity ( group of risk ) |
During pregnancy blood should be tested in each 4 weeks ( nonspecific antibodies ). |
* Dubins’ka G.M., Izums’ka Î.Ì., Kozuk P.Ì., etc.
Toxoplasmosis. Clinic, diagnostics and treatment. //Infectology. Guide
of specialist. January, 2003, ¹1 (129).
|
|
Test kits for the diagnostics of rubella virus
DIA-Rubella-IgG – Enzyme immunoassay for the quantitative detection of IgG class antibodies against Rubella Virus
DIA-Rubella-IgÌ – Enzyme immunoassay for the detection of IgM class antibodies against Rubella Virus
DIA-Rubella-IgG

Principle of the method: two stage procedure based on indirect solid ELISA
Clinical material: human serum or plasma
Quantitative detection of the concentration of specific IgG antibodies to Rubella virus in International units (IU)
Internal calibrators of the kit are titrated against 1 International standard Anti-Rubella Immunoglobulin, Human, RUBI-1-94
Immunosorbent – purified specific antigens of Rubella virus
Conjugate – high specific monoclonal antibodies to human IgG antibodies conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 1,5 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with specific antigens of Rubella virus
|
|
adding of sera and controls
incubation for 30 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25°Ñ
reaction termination
result reading
|
DIA-Rubella-IgÌ

Principle of the method: two stage ELISA procedure based on «IgM-capture» principle
Clinical materials: human serum or plasma
Detection of specific to Rubella virus IgM antibodies
Immunosorbent – monoclonal antibodies to human IgM
Conjugate – purified antigen of Rubella virus conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 1,5 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with monoclonal antibodies to human IgM
|
|
adding of sera
incubation for 30 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25°Ñ
reaction termination
result reading
|
Results on testing of serum panels containing antibodies to Rubella
virus in mixed titers: anti-Rubella Mixed Titer Performance Panel
PTR201, manufactured by BBI (USA) and positive controls Accurun 140
Rubella IgG Positive Control (BBI, USA) and Accurun 141 Rubella IgM
Positive Control (BBI, USA) in DIA-Rubella-IgG and DIA-Rubella-IgÌ test
kits are correspond to the data sheets.
Registration rate of IgG to T.gondii in different age groups
|
|
Test kit for the diagnostics of herpes virus infection and differential diagnostics of genital herpes virus.
DIA-HSV 1/2-IgG
– Enzyme immunoassay for the qualitative and semiquantitative
detection of IgG class antibodies against Herpes Simplex Virus 1 and 2
types
DIA-HSV 1/2-IgÌ – Enzyme immunoassay for the detection of IgM class antibodies against Herpes Simplex Virus 1 and 2 types
DIA-HSV 2-IgG
– Enzyme immunoassay for the qualitative and semiquantitative
detection of IgG class antibodies against Herpes Simplex Virus 2 type
DIA-HSV 2-IgÌ – Enzyme immunoassay for the detection of IgM class antibodies against Herpes Simplex Virus 2 type
Structure of Herpes Simplex Virus
DIA- HSV 1/2-IgG and DIA- HSV 2-IgG

Principle of the method: two stage ELISA based on «IgM-cupture» principle
Clinical materials: human serum or plasma
DIA-HSV ½-IgM: Detection of specific IgM antibodies to herpes simplex virus 1 and 2 types
DIA-HSV 2-IgM: Detection of specific IgM antibodies to herpes simplex virus 2 type
Immunosorbent – monoclonal antibodies to human IgM
Conjugate:
DIA-HSV ½-IgM: specific purified recombinant antigens gG1 HSV1 and gG2 HSV2 conjugated with horseradish peroxidase;
DIA-HSV 2-IgM: specific purified recombinant antigen of herpes simplex virus 2 (gG2) conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 2 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with antigens of herpes simplex virus 1 and 2
|
|
adding of sera and controls
incubation for 60 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25°Ñ
reaction termination
result reading
|
DIA-HSV 1/2-IgÌ and DIA-HSV 2-IgM

Principle of the method: two stage ELISA procedure based on «IgM-capture» principle
Clinical materials: human serum or plasma
Detection of specific to Rubella virus IgM antibodies
Immunosorbent – monoclonal antibodies to human IgM
Conjugate – purified antigen of Rubella virus conjugated with horseradish peroxidase
Packing configuration:
- strip (lockwell) microplate
- TMB chromogen
- 96 tests
Incubation time: 1,5 hours
Shelf life: 12 months
|
Assay principle |
|
wells coated with monoclonal antibodies to human IgM
|
|
adding of sera
incubation for 60 minutes, 37°Ñ
|
|
adding of conjugate
incubation for 30 minutes, 37°Ñ
|
|
adding of chromogen
incubation for 30 minutes, 18-25 °Ñ
reaction termination
result reading
|
Results obtained during testing of serum panels containing of
antibodies to herpes simplex virus 1 and 2 in mixed titers - Anti-HSV
type 1and 2 Mixed Titer Performance Panel PTH201, manufactured by BBI
(USA) and Accurun 150 HSV IgG Positive Control (BBI, USA) in DIA-HSV
½-IgG and DIA-HSV ½-IgÌ kits are correspond to the data
sheets.
Dynamics of serological markers during herpes infection
|
|
|
|
|
|
|
  |